My Beauty Spot Acne Buster

Description

The product is identified by SPL code 34089-3 and is formulated as a topical patch. Each patch contains 0.725 g of the active ingredient and is designed for direct application to the skin. The patches are round, with a diameter of 1.5 cm. Inactive ingredients include hydrocolloid, polyisobutylene, adhesive, and other excipients as specified in the formulation.

Uses and Indications

This drug is indicated for the soothing and reduction of redness and irritation associated with blemished skin. It also aids in the absorption of excess oil, promoting faster healing of affected areas.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to instruct patients to begin by cleansing and drying the face thoroughly, ensuring that any makeup is completely removed. Following this preparation, patients should apply one healing dot, ensuring the sticky side is placed directly over the blemish.

The healing dot should be left in place for a minimum of 6 hours; however, it is permissible for patients to leave it on overnight for enhanced efficacy. Patients may repeat this process as necessary, using a new healing dot for each application.

Contraindications

Use of this product is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control center is advised.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid concurrent use of this product with other topical acne medications, as this may increase the likelihood of skin irritation and dryness. In the event of irritation, it is recommended that patients limit their use to one topical acne medication at a time.

The ingredients in this formulation adhere to stringent quality standards; however, sensitivity reactions may occur in rare instances. Should any signs of sensitivity arise, patients must discontinue use immediately and seek appropriate medical advice.

In cases of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients discontinue the use of all topical acne medications and limit their regimen to one product at a time.

While the ingredients in this formulation are of high quality and sensitivity reactions are infrequent, should any sensitivity occur, patients are advised to discontinue use immediately.

Drug Interactions

Concurrent use of topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one at a time to minimize the potential for adverse effects. If irritation occurs, the patient should discontinue the use of additional topical agents and consult a healthcare professional for further guidance.

Packaging & NDC

Below are the non-prescription pack sizes of My Beauty Spot Acne Buster (salicylic acid 0.5%). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions for pregnant patients remain undefined. Healthcare professionals should exercise caution when prescribing this product to women of childbearing potential and consider the lack of information when assessing the potential risks and benefits for pregnant patients. It is advisable to monitor any developments in the literature regarding the use of this product in pregnancy and to counsel patients accordingly.

Lactation

There is no specific information regarding the use of MY BEAUTY SPOT ACNE BUSTER (salicylic acid 0.5% patch) in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, there is currently no specific information available regarding the effects or management of such occurrences. Healthcare professionals are advised to monitor the patient closely for any unusual symptoms and to provide supportive care as necessary.

In the absence of detailed guidance, it is recommended that healthcare providers consult local poison control centers or relevant medical authorities for further assistance in managing potential overdosage situations. Continuous assessment of the patient's condition is essential to ensure appropriate interventions are implemented promptly.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has indicated that the ingredients used in this product adhere to the highest quality standards. Instances of sensitivity have been reported, although these occurrences are infrequent. In the event of sensitivity, it is advised to discontinue use immediately.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. In the event that the medication is swallowed, patients should be instructed to seek medical help or contact a Poison Control center immediately. It is important for patients to understand the potential risks associated with improper use and the necessary steps to take in case of an emergency.

Storage and Handling

The product is supplied in a configuration that ensures optimal handling and storage. It should be stored in a cool, dry place to maintain its integrity and effectiveness. It is essential to keep the product out of reach of children to prevent accidental ingestion. Once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the likelihood of skin irritation and dryness increases when using this product concurrently with other topical acne medications. If irritation occurs, patients should limit their use to one topical acne medication at a time.

The formulation is composed of high-quality ingredients, and while sensitivity is rare, patients should discontinue use immediately if any adverse reactions occur. It is essential to keep the product out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a Poison Control center is recommended.

Drug Information (PDF)

This file contains official product information for My Beauty Spot Acne Buster, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)